2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Keyword Index<br />
Sardinia: C09.6<br />
Sardinian: C10.4<br />
Saudi Arabia: P10.47, P10.73<br />
Saudi: P16.06<br />
SC phocomelia/Roberts Syndrome:<br />
P02.102<br />
SCA 10: P02.011<br />
SCA: P12.145<br />
SCA15/16: P12.146<br />
SCA15: P12.145<br />
SCA2: P10.74<br />
SCA6 mutation: P12.030<br />
scalp defects: C16.3<br />
SCARB2: P08.07<br />
SCD-EDS: C04.1<br />
Schinzel-Giedion: P02.103<br />
Schizophrenia brain: P03.006<br />
Schizophrenia: C05.5, C17.2, P02.104,<br />
P03.050, P09.002, P09.030, P09.072,<br />
P09.112, P09.113, P09.128<br />
SCID: P02.082<br />
SCN1A: P17.63, P17.65, P17.67, P17.71<br />
SCN1B: P17.68<br />
SCN5A GENE: P16.20<br />
Scoring system: P05.48<br />
screening method: P06.079<br />
SCREENING METHODS: P02.117<br />
screening programs: P08.58<br />
screening: C18.3, P01.46, P06.110,<br />
P11.060<br />
SDHB: P06.038<br />
SDHD: P06.038, P06.085<br />
second-generation sequencing: C06.5<br />
SEDL: P02.166<br />
SEDT-PA: P02.105<br />
Segawa syndrome: P14.18<br />
Segmentation defects <strong>of</strong> the vertebrae:<br />
P02.161<br />
seizures: P02.188<br />
selection: P10.55<br />
semen analysis: P03.037<br />
semidominant inheritance: P12.055<br />
Semiquantitative multiplex PCR assay:<br />
P11.108<br />
senescence: S14.1<br />
Sensory-Motor Neuropathy: P10.37<br />
Sepsis: P09.061<br />
sequence specific primer: P03.028<br />
sequence variability: P10.72<br />
sequence variation nomenclature: P11.080<br />
sequence: P11.059, P11.060<br />
Sequencing: P02.172, P11.035, P11.109,<br />
P11.110, P11.119, P15.14<br />
SERCA2: P12.087, P12.088<br />
Serotonin transporter gene: P09.114<br />
serotonin transporter: P09.070<br />
serotonin: P09.092<br />
SERPINA1: P11.091<br />
SERPINC1 gene: P02.114<br />
SERT gene: P09.019<br />
serum triglycerides: P10.06<br />
serum: P06.057<br />
severe oligozoospermia: P03.193<br />
sex determination: P02.143, P04.33,<br />
P05.09<br />
sex ratio: P02.106<br />
sex reversal: P05.42<br />
sexreversal: P03.051, P03.202<br />
SGCD: P14.12<br />
SH2D1A: P12.169<br />
SH3BP2 gene: P02.018<br />
SHANK3: C16.5<br />
shared genetic susceptibility locus: C10.5<br />
SHFM3: P05.34<br />
SHH: P12.147<br />
short RNA: P11.072<br />
short stature: P07.06<br />
short tandem repeats: P10.75, P10.76<br />
SHOX gene: P02.107<br />
SHOX2: C11.2<br />
Siberian populations: P10.72<br />
sickle cell disease: P11.094<br />
sickle cell gene: P10.73<br />
Silent mutation: P08.21<br />
Silver-Russell syndrome: C08.5, P02.108<br />
SILVER-RUSSELL: P02.030<br />
Simpson-Golabi-Behmel: P03.079<br />
sindrome: P03.137<br />
single cell: C01.1, P11.070<br />
single gene disorder: P05.27<br />
Single median maxillary central incisor:<br />
P03.029<br />
single nucleotide polymorphism (SNP):<br />
P08.26, P11.111<br />
single nucleotide polymorphism: P06.054,<br />
P06.202, P08.12, P08.63, P09.069,<br />
P09.070<br />
single nucleotide polymorphisms: C06.4,<br />
P08.59, P09.039, P09.081, P17.12<br />
siRNA: P06.175, P11.029, P11.092<br />
Situs inversus totalis: P02.079<br />
situs inversus: P03.138<br />
skeletal dysplasia: P02.162<br />
Skeletal malformations: P02.024<br />
skewed X-inactivation: P04.29<br />
skin cancer: P06.086<br />
skull defect: P03.179<br />
SLC29A3: PL2.3<br />
SLC2A1: P13.21<br />
SLC39A13: C04.1<br />
SLC40A1: P14.19<br />
SLC6A8: P02.201<br />
SLC7A7: P12.105, P12.106<br />
SLE: P09.119<br />
Slug: P06.087<br />
SMA: P12.148, P12.149<br />
small RNAs: C01.4<br />
SMC1A gene: P12.048<br />
Smith-Lemli-Opitz syndrome: P02.163<br />
Smith-Magenis Syndrome: C02.1<br />
SMN gene: P12.150<br />
SMN1: P10.78, P12.149<br />
SMN2: P10.78, P14.20<br />
smoking: P02.020<br />
SMPD1: P12.121<br />
SMRT array: P12.151<br />
SMS1: P11.044<br />
Snapback primers: P11.004<br />
SNP array: P03.011, P12.152<br />
SNP arrays: P02.068<br />
snp microarrays: P08.55<br />
SNP polymorphism: P06.089<br />
SNP typing: P11.070<br />
SNP: P02.177, P05.15, P06.031, P06.037,<br />
P08.24, P09.115, P10.31, P11.019,<br />
P11.055, P11.083, P13.03<br />
SNPlotype: P09.121<br />
SNPs array: P03.102<br />
SNPs: P08.04, P09.126<br />
sociobiology: PL3.2<br />
sodium channel gene: P17.69<br />
sodium pertechnetate: P03.041<br />
s<strong>of</strong>tware: P11.123<br />
SOLiD sequencing systems: P11.084<br />
solid tumor: P06.174<br />
solid tumors: P07.10<br />
SOLiD: P06.027, P11.112, P11.113,<br />
P11.117, P11.119<br />
somatic K-ras protooncogene mutation:<br />
P06.208<br />
somatic mosaicism: P03.108<br />
somatic mutation: P12.043<br />
sonic hedgehog: P11.096, S15.3<br />
SOS1: P02.142, P13.27<br />
SOX14: P11.114<br />
Sp1 polymorphism: P09.034<br />
spectrum <strong>of</strong> CF mutations: P02.121<br />
spectrum <strong>of</strong> disease genes: C13.5<br />
sperm aneuploidy: P03.052<br />
spermatogenesis: P03.198<br />
spermine synthase (SMS) gene: P02.196<br />
spermiogenesis: C07.3<br />
SPG11: P12.085, P12.153<br />
SPG4 gene: P12.083<br />
SPG4 mutations: P12.154<br />
SPG42: P12.084<br />
Spinal dysostoses: P02.164<br />
spinal muscular athrophy: P12.155